Strongbridge Biopharma (SBBP) - Management Comments

Strongbridge Biopharma (SBBP) – Management Comments

Mar 22, 2021 05:55 AM Strongbridge Biopharma (SBBP) Announces Detailed Results from Pivotal Phase 3 LOGICS Study of RECORLEV (levoketoconazole) at ENDO 2021 Meetings
Feb 16, 2021 07:07 AM Strongbridge Biopharma (SBBP) Announces Promotion of Richard S. Kollender to President and Chief Financial Officer
Nov 24, 2020 07:36 AM
Sep 8, 2020 06:35 AM
Jul 7, 2020 07:32 AM
Jul 1, 2020 07:32 AM
Nov 18, 2019 07:31 AM
Sep 19, 2019 07:31 AM
Mar 25, 2019 07:34 AM
Mar 11, 2019 07:33 AM
Nov 1, 2018 08:19 AM
Aug 8, 2018 06:40 AM
Apr 2, 2018 07:33 AM
Jan 17, 2018 07:01 AM
Jun 27, 2017 07:33 AM
Dec 23, 2016 08:08 AM
Dec 7, 2015 07:33 AM